- Home
- RAPP vs POET Comparison
RAPP vs POET Comparison
Compare RAPP & POET Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RAPP
- POET
- Stock Information
- Founded
- RAPP 2022
- POET 1972
- Country
- RAPP United States
- POET Canada
- Employees
- RAPP N/A
- POET N/A
- Industry
- RAPP
- POET Semiconductors
- Sector
- RAPP
- POET Technology
- Exchange
- RAPP Nasdaq
- POET Nasdaq
- Market Cap
- RAPP 439.4M
- POET 450.6M
- IPO Year
- RAPP 2024
- POET N/A
- Fundamental
- Price
- RAPP $15.40
- POET $5.77
- Analyst Decision
- RAPP Strong Buy
- POET Strong Buy
- Analyst Count
- RAPP 2
- POET 2
- Target Price
- RAPP $35.00
- POET $6.25
- AVG Volume (30 Days)
- RAPP 170.4K
- POET 3.3M
- Earning Date
- RAPP 08-11-2025
- POET 08-13-2025
- Dividend Yield
- RAPP N/A
- POET N/A
- EPS Growth
- RAPP N/A
- POET N/A
- EPS
- RAPP N/A
- POET N/A
- Revenue
- RAPP N/A
- POET $199,477.00
- Revenue This Year
- RAPP N/A
- POET $8,377.56
- Revenue Next Year
- RAPP N/A
- POET $1,061.73
- P/E Ratio
- RAPP N/A
- POET N/A
- Revenue Growth
- RAPP N/A
- POET N/A
- 52 Week Low
- RAPP $6.43
- POET $2.27
- 52 Week High
- RAPP $29.74
- POET $7.79
- Technical
- Relative Strength Index (RSI)
- RAPP N/A
- POET 50.72
- Support Level
- RAPP N/A
- POET $5.64
- Resistance Level
- RAPP N/A
- POET $6.43
- Average True Range (ATR)
- RAPP 0.00
- POET 0.53
- MACD
- RAPP 0.00
- POET -0.16
- Stochastic Oscillator
- RAPP 0.00
- POET 14.50
About RAPP Rapport Therapeutics Inc. Common Stock
Rapport Therapeutics Inc is a clinical-stage biopharmaceutical company focused on discovery and development of transformational small-molecule medicines for patients suffering from central nervous system disorders. Its foundational science has elucidated the complexities of neuronal receptor biology and enables the company to map and target certain neuronal receptor complexes. Neuronal receptors are complex assemblies of proteins, comprising receptor principal subunits and their receptor-associated proteins (RAPs), the latter of which play crucial roles in regulating receptor expression and function.
About POET POET Technologies Inc.
POET Technologies Inc is a design and development company offering high-speed optical engines, light source products, and custom optical modules to the artificial intelligence systems market and hyperscale data centers. Its integration solutions are based on the POET Optical Interposer, a novel, patented platform that allows the seamless integration of electronic and photonic devices into a single chip using wafer-level semiconductor manufacturing techniques. POET's Optical Interposer platform also solves device integration challenges across a broad range of communication, computing, and sensing applications. The company operates geographically in the United States, Canada, Singapore and China.